Human prothrombin complex (Lanzhou Lansheng Blood Products)

人凝血酶原复合物（兰州兰生血液制品）

Report date: 2024/10/15 17:14:05

Base Information

Drug NameHuman prothrombin complex (Lanzhou Lansheng Blood Products)
Drug Alias Name凝血酶原复合体浓缩物 - 兰州兰生
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIIProthrombinCoagulation factor IX +[4] 
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsHemophilia B
Approved Indications in ChinaHemophilia B
Original Approved Country/TerritoryMainland China
Original Approved Date2024/09/26
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLanzhou Lansheng Blood Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLanzhou Lansheng Blood Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A